Plant ID: NPO8210
Plant Latin Name: Trigonella foenum-graecum
Taxonomy Genus: Trigonella
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
78534
Plant-of-the-World-Online:
523957-1
Anticholesterolemic; Antiinflammatory; Antiphlogistic; Antitumor; Appetizer; Cardiotonic; Carminative; Demulcent; Deobstruent; Diuretic; Emollient; Expectorant; Febrifuge; Galactogogue; Hypoglycaemic; Hypotensive; Laxative; Parasiticide; Restorative
Canada; Afghanistan; Italy; Bangladesh; Sudan; Kuwait; Mali; France; Ethiopia; Argentina; Turkmenistan; Israel; Lebanon; Iran; Algeria; Turkey; Jordan; Zimbabwe; China; Chile; Belgium; Germany; Iraq; Spain; Ukraine; Nepal; Libya; Oman; Tanzania; Indonesia; Saudi Arabia; Tajikistan; Morocco; Kenya; Switzerland; Yemen; Russia; Bulgaria; Pakistan; Romania; Albania; Portugal; Myanmar; Tunisia; Cyprus; India; Uzbekistan; Austria; Mozambique; Greece; Hungary; Fiji
TDP1; BLM; | |
CA7; CA4; CA12; CA9; | |
KDM4E; | |
NFKB1; | |
FUT7; | |
SLCO1B1; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Transferase | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Q11130 | CHEMBL3596077 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.346E-10 | 5.108E-06 | CA12, CA4, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.003E-08 | 1.093E-04 | CA12, CA4, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.305E-08 | 1.673E-04 | CA12, CA4, CA7, CA9 |
MF | GO:0005488; binding | GO:0046914; transition metal ion binding | 1.937E-07 | 7.394E-04 | BLM, CA12, CA4, CA7, CA9, CYP19A1, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.790E-06 | 5.568E-03 | CYP19A1, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 2.924E-06 | 7.076E-03 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 4.224E-06 | 9.198E-03 | CYP19A1, CYP2C9, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.556E-10 | 2.596E-08 | CA12, CA4, CA7, CA9 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.828E-04 | 6.671E-03 | CYP2C9, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; CA9; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |